dimethylformamide has been researched along with interleukin-8 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Barclay, CG; Brennand, JE; Calder, AA; Kelly, RW | 1 |
Ashby, CR; Koya, J; Munnangi, S; Pekson, R; Reznik, SE; Salami, OO; Wei, ZH | 1 |
2 other study(ies) available for dimethylformamide and interleukin-8
Article | Year |
---|---|
Interleukin-8 production by the human cervix.
Topics: Abortifacient Agents, Nonsteroidal; Alprostadil; Analysis of Variance; Cervix Uteri; Culture Techniques; Dimethylformamide; Dinoprostone; Ethers, Cyclic; Female; Humans; Interleukin-8; Lipopolysaccharides; Menopause; Okadaic Acid; Phosphoprotein Phosphatases; Pregnancy; Progesterone; Radioimmunoassay; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 1993 |
N,N-Dimethylformamide Delays LPS-Induced Preterm Birth in a Murine Model by Suppressing the Inflammatory Response.
Topics: Acetamides; Animals; Anti-Inflammatory Agents; Dimethylformamide; Disease Models, Animal; Excipients; Female; Humans; Infant, Newborn; Inflammation; Interleukin-6; Interleukin-8; Lipopolysaccharides; Mice; NF-kappa B; NF-KappaB Inhibitor alpha; Placenta; Pregnancy; Premature Birth; Solvents; Tumor Necrosis Factor-alpha | 2022 |